Desert Gateway Inc. (RTRX) 14.50 $RTRX
Nasdaq stocks posting largest percentage increases
AP - Thu Apr 17, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Retrophin Updates Financial Guidance for 2014 and 2015 and Provides Corporate Update
Business Wire - Mon Apr 14, 6:00AM CDT
Retrophin, Inc. (NASDAQ:RTRX) today announced it is updating its revenue outlook for 2014 and 2015.
FDA Recommendations, Study Publications, Recognitions, Agreements, and Acquisitions - Analyst Notes on MannKind, Acceleron, Steris, Retrophin, and NxStage Medical
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding MannKind Corp. (NASDAQ: MNKD), Acceleron Pharma, Inc. (NASDAQ: XLRN), Steris Corp. (NYSE: STE), Retrophin, Inc. (NASDAQ: RTRX), and NxStage Medical, Inc. (NASDAQ: NXTM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Brinson Patrick Re-launches Research Department
PR Newswire - Thu Apr 10, 7:21AM CDT
Brinson Patrick Securities Corporation ("Brinson Patrick"
announced today that the firm has re-launched its equity research department with the recent initiation of coverage on several life sciences companies. The research effort is being spearheaded by Christopher James, M.D., Managing Director and Senior Equity Research Analyst.
Pre-Market Scans on Equities Hitting New Highs -- Research on VMware, Northrop Grumman, Retrophin, and Siliconware Precision Industries
PR Newswire - Thu Apr 03, 7:22AM CDT
On Wednesday, April 02, 2014, the NASDAQ Composite finished at 4,276.46, up 0.20%. The Dow Jones Industrial Average closed the session at 16,573.00, up 0.24% and the S&P 500 ended the day at 1,890.90, higher by 0.29%. The gains were broad based with eight out of ten sectors ending the session in positive. Investor-Edge looks at some of the equities that hit a new 52-week high during the last session. These include VMware Inc. (NYSE: VMW), Northrop Grumman Corp. (NYSE: NOC), Retrophin Inc. (NASDAQ: RTRX) and Siliconware Precision Industries Co. (NASDAQ: SPIL). Free technical research on VMW, NOC, RTRX and SPIL can be downloaded upon signing up at:
3 Biotech Stocks Rising on Unusual Volume
at The Street - Tue Apr 01, 5:00AM CDT
Keep these biotech stocks on your radar.
Retrophin Reports Full-Year 2013 Financial Results
Business Wire - Thu Mar 27, 8:11AM CDT
Retrophin, Inc. (NASDAQ:RTRX) today reported its financial results for the year ended December 31, 2013.
The NASDAQ Stock Market Leads U.S. Exchanges for IPOs in Q1 2014
GlobeNewswire - Thu Mar 27, 7:50AM CDT
74 New U.S. Listings Including 45 IPOs
Retrophin Completes Acquisition of Manchester Pharmaceuticals
Business Wire - Thu Mar 27, 7:01AM CDT
Retrophin, Inc. (NASDAQ:RTRX) today announced the completion of the previously announced acquisition of Manchester Pharmaceuticals LLC for a total of $62.5 million, including an upfront payment of $29.5 million, plus other payments based on product sales.
Retrophin (RTRX) Catches Eye: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 8:54AM CDT
Retrophin was a big mover last session, with shares rising nearly 8% on the day.
5 Stocks With Big Insider Buying
at The Street - Wed Mar 12, 10:44AM CDT
Insiders at the companies have been scooping up shares of their own stocks lately.
Will Retrophin (RTRX) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 9:34AM CDT
Will Retrophin (RTRX) Continue to Surge Higher?
'Mad Money' Lightning Round: Zynga Can Go Higher
at The Street - Sat Mar 08, 5:00AM CST
Cramer is staying away from Solazyme but thinks Retrophin is too frothy.
Nasdaq stocks posting largest percentage increases
AP - Thu Apr 17, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Retrophin Updates Financial Guidance for 2014 and 2015 and Provides Corporate Update
Business Wire - Mon Apr 14, 6:00AM CDT
Retrophin, Inc. (NASDAQ:RTRX) today announced it is updating its revenue outlook for 2014 and 2015.
FDA Recommendations, Study Publications, Recognitions, Agreements, and Acquisitions - Analyst Notes on MannKind, Acceleron, Steris, Retrophin, and NxStage Medical
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding MannKind Corp. (NASDAQ: MNKD), Acceleron Pharma, Inc. (NASDAQ: XLRN), Steris Corp. (NYSE: STE), Retrophin, Inc. (NASDAQ: RTRX), and NxStage Medical, Inc. (NASDAQ: NXTM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Brinson Patrick Re-launches Research Department
PR Newswire - Thu Apr 10, 7:21AM CDT
Brinson Patrick Securities Corporation ("Brinson Patrick"
announced today that the firm has re-launched its equity research department with the recent initiation of coverage on several life sciences companies. The research effort is being spearheaded by Christopher James, M.D., Managing Director and Senior Equity Research Analyst. Pre-Market Scans on Equities Hitting New Highs -- Research on VMware, Northrop Grumman, Retrophin, and Siliconware Precision Industries
PR Newswire - Thu Apr 03, 7:22AM CDT
On Wednesday, April 02, 2014, the NASDAQ Composite finished at 4,276.46, up 0.20%. The Dow Jones Industrial Average closed the session at 16,573.00, up 0.24% and the S&P 500 ended the day at 1,890.90, higher by 0.29%. The gains were broad based with eight out of ten sectors ending the session in positive. Investor-Edge looks at some of the equities that hit a new 52-week high during the last session. These include VMware Inc. (NYSE: VMW), Northrop Grumman Corp. (NYSE: NOC), Retrophin Inc. (NASDAQ: RTRX) and Siliconware Precision Industries Co. (NASDAQ: SPIL). Free technical research on VMW, NOC, RTRX and SPIL can be downloaded upon signing up at:
3 Biotech Stocks Rising on Unusual Volume
at The Street - Tue Apr 01, 5:00AM CDT
Keep these biotech stocks on your radar.
Retrophin Reports Full-Year 2013 Financial Results
Business Wire - Thu Mar 27, 8:11AM CDT
Retrophin, Inc. (NASDAQ:RTRX) today reported its financial results for the year ended December 31, 2013.
The NASDAQ Stock Market Leads U.S. Exchanges for IPOs in Q1 2014
GlobeNewswire - Thu Mar 27, 7:50AM CDT
74 New U.S. Listings Including 45 IPOs
Retrophin Completes Acquisition of Manchester Pharmaceuticals
Business Wire - Thu Mar 27, 7:01AM CDT
Retrophin, Inc. (NASDAQ:RTRX) today announced the completion of the previously announced acquisition of Manchester Pharmaceuticals LLC for a total of $62.5 million, including an upfront payment of $29.5 million, plus other payments based on product sales.
Retrophin (RTRX) Catches Eye: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 8:54AM CDT
Retrophin was a big mover last session, with shares rising nearly 8% on the day.
5 Stocks With Big Insider Buying
at The Street - Wed Mar 12, 10:44AM CDT
Insiders at the companies have been scooping up shares of their own stocks lately.
Will Retrophin (RTRX) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 9:34AM CDT
Will Retrophin (RTRX) Continue to Surge Higher?
'Mad Money' Lightning Round: Zynga Can Go Higher
at The Street - Sat Mar 08, 5:00AM CST
Cramer is staying away from Solazyme but thinks Retrophin is too frothy.
